Massachusetts Psychiatric Society has many outstanding questions regarding the impacts this Initiative Petition would have on providers, including insurance coverage, and the impact to specific population subsets such as maternal or perinatal health. The doctors further explained their opposition by noting the broad nature of this Initiative Petition, the lack of concrete research or results from states that have legalized psilocybin, and the interplay of psilocybin (a hallucinogen) with psychosis for those suffering from schizophrenia, bipolar disorder, and unipolar disorder.

Link: https://malegislature.gov/Bills/193/H4607.pdf